Can Moisturizer Prevent Baby Eczema? What CASCADE, BEEP and New Guidelines Really Say

November 9, 2026

AI-generated illustration: Moonlit nursery with Dr. Arsy moisturizer

Research update: Can applying moisturizer early in life prevent a baby from developing eczema? Major studies have reached different conclusions. The best answer is that moisturizing may help some infants, but it cannot guarantee prevention, and results from one formula cannot be assigned to every cream. If a baby already has eczema, moisturizing is also part of an individualized care plan—a different goal from preventing a first diagnosis. ^{[1][2][4][16][17]}

By the Dr. Arsy Editorial Team · Evidence reviewed November 9, 2026

First, two questions that sound alike but are not

Primary prevention asks whether care given before eczema starts changes the chance of a new diagnosis. Managing eczema asks how to care for skin after eczema is present and how to control flares. A trial that tests one question does not automatically answer the other. For children with diagnosed atopic dermatitis, the American Academy of Dermatology (AAD) strongly recommends moisturizers as part of management; a clinician may also prescribe medicines when inflammation needs treatment. ^[16][17][18]

What the largest trials found

Study	Who and what was studied	Finding and practical limit
CASCADE, 2025	1,247 U.S. infant–parent pairs; daily whole-body emollient began by nine weeks in one group, compared with usual care in the other.	By 24 months, recorded eczema incidence was 36.1% versus 43.0%—a difference of 6.9 percentage points. The result applied to this trial's offered products and procedures, not to every moisturizer. ^[1]
BEEP, 2020	1,394 newborns with a family history of atopic disease were randomized to daily emollient plus skin-care advice or advice alone.	Among children with outcome data at two years, 23% versus 25% had eczema; the difference was not statistically significant. Follow-up to age five provides additional longer-term context. ^[2][3]
PreventADALL, 2020	2,397 newborns were enrolled in a study comparing skin and early-food interventions with control approaches.	The specific skin intervention—bath additives and facial cream—did not reduce atopic dermatitis incidence. It was a different routine from CASCADE, so the trials are not interchangeable. ^[4]

Put the CASCADE figures in perspective: in that study, approximately seven fewer children per 100 in the daily-emollient group had a recorded eczema diagnosis by age two. That is a group estimate, not a promise for an individual child. BEEP had a different population, products, setting and protocol; its two-year result did not establish a reduction. These differences make it inappropriate to turn any single trial into a universal guarantee. ^[1][2]

Why can the findings differ?

Family risk and starting point matter. BEEP enrolled infants with a family history of allergic disease; CASCADE recruited families from U.S. primary-care practices without selecting only high-risk babies. Other studies tested babies with a parent or sibling with eczema. A result in one group may not predict the same effect in another. ^[1][2][5][6]

“Moisturizer” is not one intervention. Trials differ in formulation, frequency, how soon parents begin, which body areas are covered, and what families in the comparison group actually do. The PAF phase II trial randomized 60 high-risk newborns to specific products and schedules; its small size and uncertain between-group result mean it cannot establish a winner for all infants. Other trials tested particular ceramide-containing products, a standardized regimen or a skin-care-plus-synbiotics approach. Their results should be read as tests of those whole routines, not proof for an isolated ingredient. ^{[7][8][9][10]}

Timing and measurement matter. A study may measure a clinician-recorded diagnosis at age two, visible eczema at a particular visit or the time until eczema appears. A short-term difference does not necessarily prove lasting prevention. Follow-up research matters, as do the number of children with data at the end of a study and whether families could follow their assigned routine. ^[1][3][5][6]

What do reviews and current guidelines say?

The 2022 Cochrane review brought together infant skin-care prevention studies available at the time; an earlier individual-participant analysis found no convincing overall prevention effect and reported an increased risk of local skin infections in the pooled trials. Other systematic reviews reached different conclusions in particular populations or comparisons. Reviews conducted before CASCADE could not include its later findings, and indirect comparisons of formulations do not establish that one retail product prevents eczema. ^{[11][12][13][14][15]}

In 2026, the AAD issued a conditional recommendation for moisturizing skin care to reduce the occurrence of pediatric atopic dermatitis. “Conditional” reflects a recommendation made with attention to the available evidence and individual circumstances; it is not a guarantee. The AAP's 2025 clinical report, written before the 2026 AAD guideline, took a more cautious position about universal emollient use solely for prevention. Families can ask their pediatrician how the newer guidance and their baby's circumstances fit together. ^[16][18]

If your baby already has eczema

Ask your pediatrician or pediatric dermatologist to confirm the diagnosis and give you a written plan. Eczema can look different across skin tones and can resemble other rashes. The plan may include regular use of an appropriate fragrance-free moisturizer, gentle bathing and a prescribed anti-inflammatory medicine when needed. A moisturizer supports dry skin; it is not a substitute for a prescribed treatment. The care team can explain the order and timing of each product. ^[17][18][20]

Choose a product your child's clinician considers appropriate for their age, especially in newborns, premature infants or babies with other medical conditions.
After a short, lukewarm bath, gently pat skin and apply moisturizer as advised. Avoid rubbing irritated areas.
If a product stings persistently, causes a new rash or seems to worsen the skin, stop using it and contact the care team.
Seek prompt medical advice for rapidly worsening redness, warmth, swelling, pain, crusting, oozing or fever. Ask urgently about clusters of painful blisters or a child who seems unwell.

For premature or medically fragile infants, do not assume that a term-infant prevention study applies; ask the neonatal team before applying products. Skin-care recommendations are individualized, and evidence about local infection risk deserves attention. ^[11][12][18]

Does moisturizing prevent food allergies?

Do not rely on moisturizer to prevent food allergies. PreventADALL examined food allergy separately from eczema, and the two outcomes must not be treated as the same result. Ask your pediatrician about age-appropriate feeding and whether your baby needs an individualized plan before introducing peanut or other common allergens—particularly when eczema is severe or an allergy is already suspected. ^[11][19]

A moisturizer for the family routine

Explore Dr. Arsy™ Hydration Recovery Moisturizer #003, 4 oz, a fragrance-free moisturizer made for dry, sensitive and eczema-prone skin. The prevention trials discussed above did not test #003; they do not establish that it prevents or treats eczema. For babies, check with your child's clinician before choosing a product.

Continue reading

Research and clinical references

This educational article is not a diagnosis or a substitute for personalized medical advice. Trial findings apply to the populations, products and protocols studied.

← Back to Doctor's Notes